Dexmedetomidine alleviates hippocampal neuronal damage in epilepsy through BDNF/TrkB pathway by inhibiting MeCP2. Indian Journal of Biochemistry and Biophysics (IJBB), [S. l.], v. 61, n. 4, p. 241–251, 2024. DOI: 10.56042/ijbb.v61i4.8422. Disponível em: https://or.niscpr.res.in/index.php/IJBB/article/view/8422. Acesso em: 2 jun. 2026.